Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
PLoS One ; 17(2): e0263516, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35134072

RESUMEN

The ability to determine a sound's location is critical in everyday life. However, sound source localization is severely compromised for patients with hearing loss who receive bilateral cochlear implants (BiCIs). Several patient factors relate to poorer performance in listeners with BiCIs, associated with auditory deprivation, experience, and age. Critically, characteristic errors are made by patients with BiCIs (e.g., medial responses at lateral target locations), and the relationship between patient factors and the type of errors made by patients has seldom been investigated across individuals. In the present study, several different types of analysis were used to understand localization errors and their relationship with patient-dependent factors (selected based on their robustness of prediction). Binaural hearing experience is required for developing accurate localization skills, auditory deprivation is associated with degradation of the auditory periphery, and aging leads to poorer temporal resolution. Therefore, it was hypothesized that earlier onsets of deafness would be associated with poorer localization acuity and longer periods without BiCI stimulation or older age would lead to greater amounts of variability in localization responses. A novel machine learning approach was introduced to characterize the types of errors made by listeners with BiCIs, making them simple to interpret and generalizable to everyday experience. Sound localization performance was measured in 48 listeners with BiCIs using pink noise trains presented in free-field. Our results suggest that older age at testing and earlier onset of deafness are associated with greater average error, particularly for sound sources near the center of the head, consistent with previous research. The machine learning analysis revealed that variability of localization responses tended to be greater for individuals with earlier compared to later onsets of deafness. These results suggest that early bilateral hearing is essential for best sound source localization outcomes in listeners with BiCIs.


Asunto(s)
Pérdida Auditiva Bilateral/fisiopatología , Localización de Sonidos/fisiología , Estimulación Acústica/métodos , Adulto , Factores de Edad , Edad de Inicio , Anciano , Anciano de 80 o más Años , Percepción Auditiva/fisiología , Implantación Coclear/métodos , Implantes Cocleares/efectos adversos , Señales (Psicología) , Sordera/fisiopatología , Femenino , Audición/fisiología , Pérdida Auditiva/fisiopatología , Pruebas Auditivas , Humanos , Masculino , Persona de Mediana Edad , Sonido
2.
Sci Transl Med ; 6(225): 225ra29, 2014 Feb 26.
Artículo en Inglés | MEDLINE | ID: mdl-24574340

RESUMEN

Diseases of failed inflammation resolution are common and largely incurable. Therapeutic induction of inflammation resolution is an attractive strategy to bring about healing without increasing susceptibility to infection. However, therapeutic targeting of inflammation resolution has been hampered by a lack of understanding of the underlying molecular controls. To address this drug development challenge, we developed an in vivo screen for proresolution therapeutics in a transgenic zebrafish model. Inflammation induced by sterile tissue injury was assessed for accelerated resolution in the presence of a library of known compounds. Of the molecules with proresolution activity, tanshinone IIA, derived from a Chinese medicinal herb, potently induced inflammation resolution in vivo both by induction of neutrophil apoptosis and by promoting reverse migration of neutrophils. Tanshinone IIA blocked proinflammatory signals in vivo, and its effects are conserved in human neutrophils, supporting a potential role in treating human inflammation and providing compelling evidence of the translational potential of this screening strategy.


Asunto(s)
Abietanos/farmacología , Antiinflamatorios/farmacología , Movimiento Celular/efectos de los fármacos , Ensayos Analíticos de Alto Rendimiento , Inflamación/tratamiento farmacológico , Infiltración Neutrófila/efectos de los fármacos , Neutrófilos/efectos de los fármacos , Pez Cebra , Animales , Animales Modificados Genéticamente , Apoptosis/efectos de los fármacos , Células Cultivadas , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Proteínas Fluorescentes Verdes/biosíntesis , Proteínas Fluorescentes Verdes/genética , Humanos , Inflamación/genética , Inflamación/inmunología , Inflamación/metabolismo , Inflamación/patología , Larva , Neutrófilos/inmunología , Neutrófilos/metabolismo , Neutrófilos/patología , Transducción de Señal/efectos de los fármacos , Factores de Tiempo , Investigación Biomédica Traslacional , Pez Cebra/embriología , Pez Cebra/genética , Pez Cebra/inmunología , Pez Cebra/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA